Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. (Q33899971)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target. |
scientific article |
Statements
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target (English)
Peter J Cook
Ram Kannan
Esther Sanchez de Leon
Alexander Drilon
Marc K Rosenblum
Maurizio Scaltriti
1 reference
1 reference
1 reference
1 reference